Physician profile
Wayne Wayfu Chan
NPI 1013275114
$6,872.99
in general payments reported to CMS, 2019-2025
13 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,006 · 2020: $24.55 · 2021: $1,419 · 2022: $1,532 · 2023: $1,546 · 2024: $75.00 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,274 · Food and Beverage: $457 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,273.51 |
| Food and Beverage | $457.19 |
| Education | $160.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $4,673.48 | 2019-2023 | |
| Encore Medical, LP | $1,191.63 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $275.63 | 2021-2024 | Blueprint Patient Specific Instrumentation |
| Exactech, INC. | $160.49 | 2023 | |
| Davol INC. | $154.03 | 2022 | |
| Depuy Synthes Sales INC. | $79.05 | 2025 | Va-Lcp |
| Catalyst Orthoscience | $74.98 | 2025 | Catalyst Total Csr, Catalyst Fracture Shoulder System, R1 Reverse Total Shoulder |
| Smith+Nephew, INC. | $69.02 | 2025 | Endobutton |
| Pacira Pharmaceuticals Incorporated | $64.02 | 2023 | Iovera, Exparel, Zilretta |
| Zimmer Biomet Holdings, INC. | $47.82 | 2023 | Accufill, Tapestry |
| Orthofix Medical, INC. | $42.86 | 2021 | |
| Pacira Therapeutics, INC. | $24.55 | 2020 | |
| Medical Device Business Services, INC. | $15.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.